US · Healthcare

Lantheus Holdings Inc (LNTH)

Drug Manufacturers - Specialty & Generic

Lantheus Holdings Inc (LNTH) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LNTH

P/E ratio

18.00

Lantheus Holdings Inc (LNTH) — FAQ

What is LNTH's P/E ratio?

The price-to-earnings (P/E) ratio for Lantheus Holdings Inc (LNTH) is 18.00 (data as of 2026-03-24).

Does Lantheus Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for Lantheus Holdings Inc (LNTH). Check the MyAverix Finance app for the latest dividend data.

What sector is Lantheus Holdings Inc in?

Lantheus Holdings Inc (LNTH) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is LNTH listed on?

LNTH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)